Efectividad y tolerabilidad del ácido zoledrónico en el tratamiento del cancer de próstata metastásico-Reference-Cited by-同舟云学术

Efectividad y tolerabilidad del ácido zoledrónico en el tratamiento del cancer de próstata metastásico

Published:2008-01 Issue:5 Volume:32 Page:492-501
ISSN:0210-4806
Container-title:Actas Urológicas Españolas
language:es
Short-container-title:Actas Urológicas Españolas

Author:

Cózar Olmo J.M.,Carballido Rodríguez J.,Luque Galvez P.,Tabernero Gómez A.G.,Barreiro Mouro A.,Sánchez Sánchez E.,González Enguita C.,Alcover García J.,García-Galisteo E.,Abascal García J.M.,Sánchez Chapado M.,GómezVeiga F.,Minguez Martínez R.J.,Rodríguez Antolín A.,Medina López R.A.,Rico Morales M.,Regadera Sejas F.J.,Búcar Terrades S.,Jamardo González D.,Gálvez R.

Publisher

Elsevier BV

Subject

Urology

Reference18 articles.

1. Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years;Guarneri;Oncologist,2005

2. Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy;Wellington;Drugs,2003

3. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer;Santini;Clin Cancer Res,2003

4. The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases;Coleman;Semin Oncol,2001

5. Future directions in the treatment and prevention of bone metastases;Coleman;Am J Clin Oncol,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salud ósea en pacientes con cáncer de próstata;Actas Urológicas Españolas;2014-12

2. Factores que predicen el desarrollo de metástasis óseas por cáncer de próstata: recomendaciones de seguimiento y opciones terapéuticas;Actas Urológicas Españolas;2014-05

3. Factors that predict the development of bone metastases due to prostate cancer: Recommendations for follow-up and therapeutic options;Actas Urológicas Españolas (English Edition);2014-05

4. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities;BJU International;2012-03-19